-
Je něco špatně v tomto záznamu ?
Protective effects of osajin in ischemia-reperfusion of laboratory rat kidney
Bartošíková L., Nečas J., Suchý V., Janoštíková E., Bartošík T., Juřica J., Florian T., Klusáková J., Frydrych M.
Jazyk angličtina Země Německo
Grantová podpora
NL7455
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
Freely Accessible Science Journals
od 2003 do Před 1 rokem
- MeSH
- antioxidancia terapeutické užití MeSH
- benzopyrany terapeutické užití MeSH
- financování organizované MeSH
- glutathionperoxidasa metabolismus MeSH
- isoflavony terapeutické užití MeSH
- krysa rodu rattus MeSH
- ledviny enzymologie patologie MeSH
- malondialdehyd metabolismus MeSH
- nemoci ledvin enzymologie patologie prevence a kontrola MeSH
- potkani Wistar MeSH
- reperfuzní poškození enzymologie patologie prevence a kontrola MeSH
- superoxiddismutasa metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
The aim of this study was to analyze the antioxidative effect of osajin during prophylactic administration. The pathological model for in vivo experiment was the unilateral ischemia-reperfusion of kidney of the laboratory rat. The animals were randomly divided into five groups. Osajin was administrated orally in doses of 5, 10 and 20 mg/kg once a day to three premedicated groups. Placebo--0.5% solution of Avicel--was given to the fourth group and the fifth group was completely intact. The premedication lasted 15 days and subsequently the ischemia of the left kidney was incited in general anaesthesia for 60 min. The reperfusion lasted 10 min and it was finished by blood collection from the left ventricle and the reperfused kidney was recovered. Selected biochemical markers were assessed in blood: superoxide dismutase, glutathion peroxidase, total antioxidative capacity and malondialdehyde. The kidney tissue samples were used for histopathological examination. Laboratory and histopathological results confirmed supposed effects of osajine. The dependence between the effect and the applied dose of osajin was linear. The best biochemical results were reached after administration of osajin at the dose of 5 mg/kg. The best histopathological results were reached after administration of osajin at the dose of 10 mg/kg.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07522670
- 003
- CZ-PrNML
- 005
- 20130603101617.0
- 008
- 090506s2006 gw e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Bartošíková, Lenka, $d 1968- $7 nlk20020124783
- 245 10
- $a Protective effects of osajin in ischemia-reperfusion of laboratory rat kidney / $c Bartošíková L., Nečas J., Suchý V., Janoštíková E., Bartošík T., Juřica J., Florian T., Klusáková J., Frydrych M.
- 314 __
- $a Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic. bartosikoval@vfu.cz
- 520 9_
- $a The aim of this study was to analyze the antioxidative effect of osajin during prophylactic administration. The pathological model for in vivo experiment was the unilateral ischemia-reperfusion of kidney of the laboratory rat. The animals were randomly divided into five groups. Osajin was administrated orally in doses of 5, 10 and 20 mg/kg once a day to three premedicated groups. Placebo--0.5% solution of Avicel--was given to the fourth group and the fifth group was completely intact. The premedication lasted 15 days and subsequently the ischemia of the left kidney was incited in general anaesthesia for 60 min. The reperfusion lasted 10 min and it was finished by blood collection from the left ventricle and the reperfused kidney was recovered. Selected biochemical markers were assessed in blood: superoxide dismutase, glutathion peroxidase, total antioxidative capacity and malondialdehyde. The kidney tissue samples were used for histopathological examination. Laboratory and histopathological results confirmed supposed effects of osajine. The dependence between the effect and the applied dose of osajin was linear. The best biochemical results were reached after administration of osajin at the dose of 5 mg/kg. The best histopathological results were reached after administration of osajin at the dose of 10 mg/kg.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antioxidancia $x terapeutické užití $7 D000975
- 650 _2
- $a benzopyrany $x terapeutické užití $7 D001578
- 650 _2
- $a glutathionperoxidasa $x metabolismus $7 D005979
- 650 _2
- $a isoflavony $x terapeutické užití $7 D007529
- 650 _2
- $a ledviny $x enzymologie $x patologie $7 D007668
- 650 _2
- $a nemoci ledvin $x enzymologie $x patologie $x prevence a kontrola $7 D007674
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a malondialdehyd $x metabolismus $7 D008315
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a reperfuzní poškození $x enzymologie $x patologie $x prevence a kontrola $7 D015427
- 650 _2
- $a superoxiddismutasa $x metabolismus $7 D013482
- 700 1_
- $a Nečas, Jiří, $d 1954- $7 nlk19990073608
- 700 1_
- $a Suchý, Václav, $d 1936- $7 jn20000402312
- 700 1_
- $a Janoštíková, Eva $7 xx0104722
- 700 1_
- $a Bartošík, Tomáš $7 xx0147653
- 700 1_
- $a Juřica, Jan $7 xx0085543
- 700 1_
- $a Florian, Tomáš $7 xx0104725
- 700 1_
- $a Klusáková, Jarmila, $d 1956- $7 mzk2005269589
- 700 1_
- $a Frydrych, Marek $7 xx0104730
- 773 0_
- $w MED00003807 $t Die Pharmazie $g Roč. 61, č. 6 (2006), s. 552-555 $x 0031-7144
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20130603101951 $b ABA008
- 999 __
- $a ok $b bmc $g 650762 $s 503925
- BAS __
- $a 3
- BMC __
- $a 2006 $b 61 $c 6 $d 552-555 $i 0031-7144 $m Die Pharmazie $x MED00003807
- GRA __
- $a NL7455 $p MZ0
- LZP __
- $a 2009-B3/ipme